Skip to main content
Top
Published in: International Urology and Nephrology 2/2018

01-02-2018 | Urology - Original Paper

Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database

Authors: Mahir Maruf, Abhinav Sidana, Stephanie Purnell, Amit L. Jain, Sam J. Brancato, Piyush K. Agarwal

Published in: International Urology and Nephrology | Issue 2/2018

Login to get access

Abstract

Purpose

Population studies of patients undergoing radical cystectomy (RC) for bladder cancer (BC) suggest that a more extended lymph node dissection (LND) increases survival. However, information regarding LNDs of patients undergoing RC with a history of radiation therapy for BC is largely unknown. This study aims to define the lymph node yield (LNY) in patients undergoing RC for BC following radiation of the bladder using the surveillance epidemiology and end results (SEER) database.

Methods

Data were collected using SEER 18 registries from 1988 to 2013 to identify patients undergoing RC for BC. Data on extent and yield of LND were obtained. Logistic regression and multivariate Cox proportional hazard regression were done to identify predictors of adequate LND and all-cause mortality, respectively.

Results

In total, 27,451 patients were identified, of which, 27,362 (99.7%) were radiation naïve and 89 (0.3%) had prior radiation therapy for BC. The average LNY in radiation naïve patients (15, SD [13.5]) was slightly higher than the LNY in patients with prior radiation (12.3 SD [9.2], p = 0.157). Prior radiation was not an independent predictor of overall mortality (HR = 1.3, 95% CI [0.98–1.7]; p = 0.076).

Conclusions

A lower proportion of patients with a history of radiation underwent a LND. The LNYs of radiation naïve patients, and those with a history of radiation, were not statistically different; however, the proportion of irradiated patients was small. Further investigation will be required to elucidate the patient and provider characteristics that contribute to the similar LNYs.
Literature
1.
go back to reference Konety BR, Joslyn SA, O’Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 169(3):946–950CrossRefPubMed Konety BR, Joslyn SA, O’Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 169(3):946–950CrossRefPubMed
2.
go back to reference Siemens DR et al (2015) Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study. Urol Oncol 33(10):425.e15–425.e23CrossRef Siemens DR et al (2015) Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: a population-based study. Urol Oncol 33(10):425.e15–425.e23CrossRef
3.
go back to reference Hollenbeck BK et al (2008) Hospital lymph node counts and survival after radical cystectomy. Cancer 112(4):806–812CrossRefPubMed Hollenbeck BK et al (2008) Hospital lymph node counts and survival after radical cystectomy. Cancer 112(4):806–812CrossRefPubMed
4.
go back to reference Herr HW et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167(3):1295–1298CrossRefPubMed Herr HW et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167(3):1295–1298CrossRefPubMed
5.
go back to reference Herr H et al (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171(5):1823–1828 (discussion 1827–1828) CrossRefPubMed Herr H et al (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171(5):1823–1828 (discussion 1827–1828) CrossRefPubMed
6.
go back to reference Leissner J et al (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817–823CrossRefPubMed Leissner J et al (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817–823CrossRefPubMed
7.
go back to reference Wright JL, Lin DW, Porter MP (2008) The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 112(11):2401–2408CrossRefPubMed Wright JL, Lin DW, Porter MP (2008) The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 112(11):2401–2408CrossRefPubMed
8.
go back to reference Abdollah F et al (2012) Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int 109(8):1147–1154CrossRefPubMed Abdollah F et al (2012) Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int 109(8):1147–1154CrossRefPubMed
9.
go back to reference Cole AP et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33(12):504.e9–504.e17CrossRef Cole AP et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33(12):504.e9–504.e17CrossRef
10.
go back to reference Hedgepeth RC et al (2011) Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology 77(2):385–390CrossRefPubMed Hedgepeth RC et al (2011) Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology 77(2):385–390CrossRefPubMed
11.
go back to reference Ramani VA et al (2010) Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis. Eur Urol 57(6):1058–1063CrossRefPubMed Ramani VA et al (2010) Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis. Eur Urol 57(6):1058–1063CrossRefPubMed
12.
go back to reference Efstathiou JA et al (2012) Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 61(4):705–711CrossRefPubMed Efstathiou JA et al (2012) Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 61(4):705–711CrossRefPubMed
13.
go back to reference Nieuwenhuijzen JA et al (2004) Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 94(6):793–797CrossRefPubMed Nieuwenhuijzen JA et al (2004) Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 94(6):793–797CrossRefPubMed
14.
go back to reference Eisenberg MS et al (2010) Early complications of cystectomy after high dose pelvic radiation. J Urol 184(6):2264–2269CrossRefPubMed Eisenberg MS et al (2010) Early complications of cystectomy after high dose pelvic radiation. J Urol 184(6):2264–2269CrossRefPubMed
15.
go back to reference Hellenthal NJ et al (2009) Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. J Urol 181(6):2490–2495CrossRefPubMed Hellenthal NJ et al (2009) Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. J Urol 181(6):2490–2495CrossRefPubMed
16.
go back to reference Herr HW et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781–2789CrossRefPubMed Herr HW et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781–2789CrossRefPubMed
17.
go back to reference Skinner EC, Stein JP, Skinner DG (2007) Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 25(1):66–71CrossRefPubMed Skinner EC, Stein JP, Skinner DG (2007) Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 25(1):66–71CrossRefPubMed
19.
go back to reference Dorin RP et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952CrossRefPubMed Dorin RP et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946–952CrossRefPubMed
20.
go back to reference van de Putte EEF et al (2015) Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template. Urol Oncol 33(12):504.e19–504.e24CrossRef van de Putte EEF et al (2015) Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template. Urol Oncol 33(12):504.e19–504.e24CrossRef
21.
go back to reference Ghersi D, Stewart LA, Palmar MKB et al. (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354(9178):533–540 Ghersi D, Stewart LA, Palmar MKB et al. (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354(9178):533–540
22.
go back to reference Mata DA et al (2015) Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 111(7):923–928CrossRefPubMedPubMedCentral Mata DA et al (2015) Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 111(7):923–928CrossRefPubMedPubMedCentral
23.
go back to reference Stein JP et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177(3):876–881 (discussion 881–882) CrossRefPubMed Stein JP et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177(3):876–881 (discussion 881–882) CrossRefPubMed
Metadata
Title
Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database
Authors
Mahir Maruf
Abhinav Sidana
Stephanie Purnell
Amit L. Jain
Sam J. Brancato
Piyush K. Agarwal
Publication date
01-02-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1751-3

Other articles of this Issue 2/2018

International Urology and Nephrology 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.